Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T M Reshetnyak

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Terapevticheskii Arkhiv|June 30, 2020
[Thrombotic microangiopathy in rheumatology: a link between thrombosis and autoimmunity]E L Nasonov, T M Reshetnyak, Z S Alekberova
Terapevticheskii Arkhiv|December 30, 2023
[Mental disorders in patients with systemic lupus erythematosus: association with activity and the course of rheumatic disease]A B Borisova, T A Lisitsyna, D Y Veltishchev, et al.
Klinicheskaia Laboratornaia Diagnostika|September 20, 2021
Study of antiphospholipid antibodies by enzyme immunoassay and chemiluminescent methods in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data)F A Cheldieva, T M Reshetnyak, M V Cherkasova, et al.
Terapevticheskii Arkhiv|December 30, 2023
[Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future]E L Nasonov, T M Reshetnyak, S K Solovyev, et al.
Terapevticheskii Arkhiv|June 30, 2026
[Cutaneous manifestations of systemic lupus erythematosus and coexisting dermatologic conditions]A A Shumilova, E I Travkina, P A Sholkina, et al.
Terapevticheskii Arkhiv|October 26, 2022
[Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome]T M Reshetnyak, F A Cheldieva, M V Cherkasova, et al.
Terapevticheskii Arkhiv|June 30, 2020
[Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range]N V Seredavkina, T M Reshetnyak, M A Satybaldyeva, et al.
Doklady. Biochemistry and Biophysics|October 13, 2023
Antibodies to Domain I β<sub>2</sub>-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus ErythematosusT M Reshetnyak, F A Cheldieva, M V Cherkasova, et al.
Doklady. Biochemistry and Biophysics|October 13, 2023
Global Antiphospholipid Syndrome Score (GAPSS) in Patients with Systemic Lupus ErythematosusF A Cheldieva, T M Reshetnyak, A A Shumilova, et al.
Terapevticheskii Arkhiv|June 3, 2024
[NETosis in lupus nephritis]T M Reshetnyak, K S Nurbaeva, I V Ptashnik, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Terapevticheskii Arkhiv|June 30, 2020
[Thrombotic microangiopathy in rheumatology: a link between thrombosis and autoimmunity]E L Nasonov, T M Reshetnyak, Z S Alekberova
Terapevticheskii Arkhiv|December 30, 2023
[Mental disorders in patients with systemic lupus erythematosus: association with activity and the course of rheumatic disease]A B Borisova, T A Lisitsyna, D Y Veltishchev, et al.
Klinicheskaia Laboratornaia Diagnostika|September 20, 2021
Study of antiphospholipid antibodies by enzyme immunoassay and chemiluminescent methods in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data)F A Cheldieva, T M Reshetnyak, M V Cherkasova, et al.
Terapevticheskii Arkhiv|December 30, 2023
[Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future]E L Nasonov, T M Reshetnyak, S K Solovyev, et al.
Terapevticheskii Arkhiv|June 30, 2026
[Cutaneous manifestations of systemic lupus erythematosus and coexisting dermatologic conditions]A A Shumilova, E I Travkina, P A Sholkina, et al.
Terapevticheskii Arkhiv|October 26, 2022
[Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome]T M Reshetnyak, F A Cheldieva, M V Cherkasova, et al.
Terapevticheskii Arkhiv|June 30, 2020
[Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range]N V Seredavkina, T M Reshetnyak, M A Satybaldyeva, et al.
Doklady. Biochemistry and Biophysics|October 13, 2023
Antibodies to Domain I β<sub>2</sub>-Glycoprotein 1 in Patients with Antiphospholipid Syndrome and Systemic Lupus ErythematosusT M Reshetnyak, F A Cheldieva, M V Cherkasova, et al.
Doklady. Biochemistry and Biophysics|October 13, 2023
Global Antiphospholipid Syndrome Score (GAPSS) in Patients with Systemic Lupus ErythematosusF A Cheldieva, T M Reshetnyak, A A Shumilova, et al.
Terapevticheskii Arkhiv|June 3, 2024
[NETosis in lupus nephritis]T M Reshetnyak, K S Nurbaeva, I V Ptashnik, et al.
Pageof 2